Skip to main content
Clinical Trials/NL-OMON24660
NL-OMON24660
Not yet recruiting
Not Applicable

Budenofalk granules and capsules in the treatment of active Crohn's disease - a prospective, multicenter, observational study

Dr. Falk Pharma Benelux B.V.0 sites138 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Crohn's disease, budesonide, Budenofalk, IBD, ziekte van Crohn
Sponsor
Dr. Falk Pharma Benelux B.V.
Enrollment
138
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
Dr. Falk Pharma Benelux B.V.

Eligibility Criteria

Inclusion Criteria

  • age \> 18 years;
  • seen in the outpatient department;
  • have been prescribed Budenofalk granules or capsules for the treatment of mild to moderate active Crohn's disease;

Exclusion Criteria

  • have severe active Crohn's disease;
  • are being treated with corticosteroids for current flare;

Outcomes

Primary Outcomes

Not specified

Similar Trials